Protecting biodiversity and human health along the belt and road

Abstract

In 2022, the 15th Conference of Parties (COP15) to the UN Convention on Biological Diversity (CBD) adopted the “Kunming-Montreal Global Biodiversity Framework” (GBF), which aimed to strengthen international protections on terrestrial and marine areas through biodiversity investments, corporate responsibility, and the elimination of environmentally damaging subsidies. China was fundamental in forming and passing this pivotal biodiversity framework. China's leadership in COP15 should result in escalated Chinese biodiversity protections, specifically through mandated biodiversity impact disclosures (BIDs) for companies associated with the Belt and Road Initiative (BRI). To achieve this, BID clauses should be inserted into BRI development agreements between Chinese foreign development institutions and BRI partner states or companies. Mandated BIDs would expand biodiversity and human health protections within China and globally. BRI-associated companies would be motivated to improve BID ratings for financial benefits, increased social capital, employee engagement, and customer loyalty. Biodiversity protection will also “future-proof” companies against any future environmental policy changes. By providing improved materiality to investors, governments, and other interested parties, BRI BIDs would enhance corporate oversight and awareness of biodiversity issues, advance the standardization and pervasiveness of BIDs, and elevate biodiversity and human health issues into more traditional commercial reporting systems. Thus, China's corporate responsibility measures under COP15 will influence global biodiversity, human health, and the future of BIDs.